As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA)
- Written by The Post
HONG KONG SAR - EQS Newswire - 22 January 2024 - Uni-Bio Science Group Limited ("Uni-Bio", the "Company", together with its subsidiaries, the "Group"), a leading biopharmaceutical company, is excited to announce that the China National Medical Products Administration ("NMPA") has officially approved the marketing application for BOGUTAI® (teriparatide injection) on January 16, 2024, with the approval number "国药准字S20240004".
